These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18652402)

  • 41. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.
    Eckstein AK; Lösch C; Glowacka D; Schott M; Mann K; Esser J; Morgenthaler NG
    Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare presentations of hyperthyroidism--Basedow's paraplegia and pancytopenia.
    Chen YH; Lin HJ; Chen KT
    Am J Emerg Med; 2009 Feb; 27(2):258.e1-2. PubMed ID: 19371562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Combined surgical treatment for corneal ulcer in endocrine ophthalmopathy].
    Grusha IaO; Kasparov AA; Kiseleva TN; Fedorov AA; Filimonov GP; Zaĭtsev AV; Polunina AA; Ismailova DS
    Vestn Oftalmol; 2008; 124(6):57-9. PubMed ID: 19205407
    [No Abstract]   [Full Text] [Related]  

  • 44. Amaurosis and optic disc blanching during upgaze in graves ophthalmopathy.
    Seery LS; Zaldívar RA; Garrity JA
    J Neuroophthalmol; 2009 Sep; 29(3):219-22. PubMed ID: 19726945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions.
    Tanda ML; Lai A; Bartalena L
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):845-7. PubMed ID: 18785990
    [No Abstract]   [Full Text] [Related]  

  • 46. Interleukin-1beta gene (IL-1beta) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population.
    Lacka K; Paradowska A; Gasinska T; Soszynska J; Wichary H; Kramer L; Lacki JK
    Curr Eye Res; 2009 Mar; 34(3):215-20. PubMed ID: 19274529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Graves' disease.
    Levy BS
    N Engl J Med; 2008 Sep; 359(13):1408; author reply 1409. PubMed ID: 18822459
    [No Abstract]   [Full Text] [Related]  

  • 48. [Ocular disturbances in neuromuscular disorders].
    Pénisson-Besnier I; Lamirel C
    Rev Neurol (Paris); 2008 Nov; 164(11):902-11. PubMed ID: 18808764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Melancholia and Basedow's disease].
    REISNER H
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 91():233-8. PubMed ID: 13981523
    [No Abstract]   [Full Text] [Related]  

  • 50. [The neurological aspect of Basedow's disease].
    COHEN EJ
    Encephale; 1962; 51():470-81. PubMed ID: 14022029
    [No Abstract]   [Full Text] [Related]  

  • 51. Rationale for radiotherapy in thyroid eye disease.
    Perry JD; Feldon SE
    Am J Ophthalmol; 2009 Dec; 148(6):818-9. PubMed ID: 19932802
    [No Abstract]   [Full Text] [Related]  

  • 52. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
    Chu EA; Miller NR; Lane AP
    Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical manifestations of thyroid ophthalmopathy].
    Fernández Hermida RV; Pinar S; Muruzábal N
    An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.
    Salvi M; Vannucchi G; Campi I; Currò N; Simonetta S; Covelli D; Pignataro L; Guastella C; Rossi S; Bonara P; Dazzi D; Ratiglia R; Beck-Peccoz P
    Clin Immunol; 2009 May; 131(2):360-5. PubMed ID: 19195932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Basedow's disease and hyperthyroidism].
    RICHARD M
    Schweiz Med Wochenschr; 1951 Dec; 81(48):1165-70. PubMed ID: 14901006
    [No Abstract]   [Full Text] [Related]  

  • 56. [Original myopathic manifestations of Basedow's disease].
    GIRAUD G; LATOUR H; LEVY A; PUECH P; BARJON P; RIBSTEIN M
    Montp Med; 1954 Dec; 46(6):679-82. PubMed ID: 14370127
    [No Abstract]   [Full Text] [Related]  

  • 57. [Basedow's ophthalmopathy].
    Raynaud L; Benois A; Lafond P
    Rev Prat; 2008 May; 58(10):1060. PubMed ID: 18652402
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pathogenetic, clinical and therapeutical features of ophthalmologic involvement in Basedow's disease].
    Verraz R
    Arch Sci Med (Torino); 1969 Sep; 126(9):699-704. PubMed ID: 17340828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Choice the appropriate therapy according to the clinical features of the thyroid associated ophthalmopathy].
    Xiao LH
    Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1060-2. PubMed ID: 17415960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current management of endocrine orbitopathy].
    Ponto KA; Kahaly GJ
    Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.